Docetaxel and Estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Patrick C. Walsh

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Docetaxel and Estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer'. Together they form a unique fingerprint.